The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Share News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.25
Bid: 24.00
Ask: 24.50
Change: -1.00 (-3.96%)
Spread: 0.50 (2.083%)
Open: 25.25
High: 25.25
Low: 24.25
Prev. Close: 25.25
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: McKay backs Workspace offer; IOG fixes Blythe fault

Wed, 13th Apr 2022 19:46

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Ediston Property Investment Co PLC - Edinburgh-based real estate investment company - Confirms sale of leisure asset at The Lanyard, Hartlepool, which is let to Mecca Bingo Ltd for GBP2.6 million, which is 16% above its most recent valuation at December 31.

----------

SulNOx Group PLC - London-based supplier of fuel conditioners - Receives certification for SulNOxEco Fuel Conditioner from Lloyd's Register Fuel Oil Bunker Analysis and Advisory Service. Lloyds found the fuel had minimal impact on ISO 8217 test parameters, without changing characteristics when added to machine fuel at the prescribed dosage rate. "Lloyd's Register is a highly respected and trusted international classification society and these results provide another significant landmark for SulNOx marine," says Nicholas Fairfax, non-executive director & Marine lead.

----------

Europa Oil & Gas (Holdings) PLC - Ireland and Morocco focused oil and gas exploration and production company - Records strongest interim performance since the first half of 2014, as revenue rises to GBP2.2 million in the six months to January 31, from GBP500,000 a year before. Swings to pretax profit of GBP700,000 from pretax loss of GBP700,000 a year prior. Attributes performance to its 30% interest in Wressle oil field in North Lincolnshire, which delivered beyond expectations.

----------

Value & Indexed Property Income Trust PLC - London-based investment manager for UK commercial properties - Says direct commercial property portfolio increases to GBP155.5 million at March 31, up from GBP110.5 million at September 30. VIP's property portfolio delivers total return of 8.8% over the six months to March 31, and 20% over the past year. " VIP is now almost fully invested after its transition to a predominantly property trust," it notes.

----------

McKay Securities PLC - South East and London-focused office property investor - Says board continues to unanimously recommend the takeover offer from Workspace Group PLC, following Tuesday's news that Canadian private equity firm Slate Asset Management did not intend to make an offer.

----------

Lekoil Ltd - oil and gas exploration and production company focused on Nigeria and West Africa - Notes the announcement from Lekoil Nigeria Ltd that it spuds the Otakikpo-4 well as part of its Phase 2 development at Otakikpo. Lekoil Nigeria also renews the Otakikpo offtake agreement with Shell Western Supply & Trading Ltd.

----------

IOG PLC - London-based gas and infrastructure operator with projects in the North Sea - Says fault at Blythe well "temporarily addressed" and the well reopened on Tuesday. "A further permanent modification on the Blythe platform has been designed and will be installed when materials are available. This permanent modification is not anticipated to involve material downtime," IOG says.

----------

Watchstone Group PLC - cash shell with remaining assets comprising litigation assets, contingent liabilities and cash - Says subsidiary WTGIL Ltd's dismissed in first-tier tribunal, with the ruling in favour of HMRC. Case concerns supplies of telematic devices or related services during VAT period 2014-2018. "WTGIL will consider the judgment with its advisers and counsel and decide on the next steps (if any) including whether to appeal to the Upper Tax Tribunal," it says.

----------

Open Orphan PLC - Notes announcement from Poolbeg Pharma PLC regarding numerous new investors expressing interest in acquiring up to GBP1.6 million of company's shares which are currently locked-up and held in trust by Croft Nominees Ltd, following the distribution in specie from Open Orphan PLC in June last year. "This arrangement has followed significant efforts to help widen the Poolbeg investor base and increase future liquidity, in order to ensure that the dividend in specie remains as beneficial as possible to shareholders of both Open Orphan and Poolbeg in the long-term," says Executive Chair Cathal Friel.

----------

Harland & Wolff Group Holdings PLC - Belfast-based offshore construction company - Says wholly-owned subsidiary Harland & Wolff (Arnish) Ltd wins fabrication contract at roll twelve Super Duplex Shells for the Hinkley C nuclear power project, to finish by the end of June. Arnish is on track to complete suction pile contract announced in November, and making progress to launch the first of eight boat landings for the Saipem contract. Cumulative value of projects is in the region of GBP2 million to GBP3 million.

----------

Bradda Head Lithium Ltd - North America-focused lithium development company - Raises GBP2.0 million through UK placing of 14.5 million shares at 13.5 pence, having received orders in excess of GBP6.6 million. This comes in addition to the North American fundraise, which raised GBP9.9 million through 73.2 shares at the same price. Non-executive director subscribed for 834,226 placing shares, bringing his total holding to 65.0 million shares, or 17% of Bradda's ordinary share capital.

----------

By Elizabeth Winter; elizabethwinter@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
31 May 2018 12:17

Sareum Regains Worldwide Rights To Leukaemia Treatment

LONDON (Alliance News) - Sareum Holdings PLC said on Thursday that it has regained its worldwide rights to a potential treatment for leukaemia and other blood-related cancers.The drug said

Read more
15 Mar 2018 13:55

Sareum Partner Sierra Oncology To Present Positive SRA737 Results

LONDON (Alliance News) - Sareum Holdings PLC said Thursday its development partner Sierra Oncology's SRA737 results have been accepted for presentation at the annual of of

Read more
9 Jan 2017 16:39

Sareum Holdings receives milestone payment

(ShareCast News) - Sareum Holdings, an AIM listed specialist cancer drug discovery and development company, has announced the attainment of a $2m milestone payment as part of the Chk1 license agreement between its co-investment partner the CRT Pioneer Fund and Sierra Oncology, formerly known as ProN

Read more
9 Jan 2017 12:19

Sareum To Receive USD550,000 From Joint Licence Success Payment

Read more
24 Oct 2016 15:02

Sareum reports positive results from TYK2 programme

(ShareCast News) - Specialist cancer drug discovery and development business Sareum announced a successful conclusion from its feasibility study into the potential for its TYK2 programme lead molecules to treat T-Cell Acute Lymphoblastic Leukaemia (T-ALL) on Monday. The AIM-traded company said the i

Read more
24 Oct 2016 08:13

Sareum Welcomes Positive Feasibility Results For Leukemia Treatment

Read more
17 Oct 2016 14:16

Sareum Holdings granted patents in Japan and Singapore

(ShareCast News) - Specialist cancer drug discovery and development company Sareum announced on Monday that the Japan and Singapore Patent Offices have issued notifications that patents will be granted for inventions associated with its Aurora+FLT3 kinase inhibitor programme. The AIM-traded firm sai

Read more
27 Sep 2016 11:13

Sareum Holdings Co-Investment Partner Inks Licence Agreement

Read more
3 Aug 2016 14:56

Sareum programme receives patents in Hong Kong and China

(ShareCast News) - Specialist cancer drug discovery and development business Sareum announced on Wednesday that the Chinese Patent Office and the Hong Kong Patents Registry have issued notifications that patents will be granted for inventions associated with the company's Aurora+FLT3 Kinase Inhibito

Read more
23 May 2016 11:06

Sareum Holdings Says Phase I CCT245737 Trials To Open End Of May

Read more
23 May 2016 11:01

*Sareum Holdings Says Phase I CCT245737 Trials To Open End Of May

Read more
17 May 2016 08:03

Sareum Appoints Silence Therapeutics' Stephen Parker As Chairman

Read more
5 Apr 2016 12:33

Sareum cancer drug candidate gets MHRA trial approval

(ShareCast News) - Sareum Holdings was pressing ahead with one of its cancer drug programmes on Tuesday, having received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) for the Clinical Trial Applications submitted for CHK1 inhibitor drug candidate CCT245737. The AIM-tra

Read more
5 Apr 2016 09:46

Sareum Holdings Gets Clinical Trial Approval For Cancer Drug Candidate

Read more
24 Mar 2016 12:03

Sareum Raises GBP1.1 Million For Drug Development Programmes (ALLISS)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.